This article is more than 5 years old. Information may no longer be current.

STAAR reports revenue growth for fourth quarter, full year

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

STAAR Surgical reported revenue of $18.9 million for the fourth quarter, a 15% increase from the corresponding quarter in 2012, according to a press release.

GAAP net loss was $876,000, or $0.02 per diluted share, for the fourth quarter, compared with a net loss of $1.4 million, or $0.04 per diluted share, for the fourth quarter 2012.

Global sales of the Visian ICL increased 31% during the fourth quarter and 26% for the full year.

For full year 2013, net sales increased to $72.2 million, up from $63.8 million in 2012, a growth of 13%. Foreign currency changes unfavorably affected net sales by $3.8 million in 2013 compared with $62,000 in 2012.

Full year 2013 net GAAP income was $397,711, or $0.01 per diluted share, compared with a loss of $1.8 million, or $0.05 per diluted share, reported in 2012.

Total revenue for the full year 2013 grew by 13% over 2012.